🔎 Trials Near Me

Gara Jalqabaatti › Non-Hodgkin Lymphoma › Nebraska › Omaha

Qorannoo klinikaalii Non-Hodgkin Lymphoma Omaha, NE keessatti

Qorannoo 14 Non-Hodgkin Lymphoma f Omaha fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Nebraska Medical Center, Omaha
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • The University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Namoota walitti qabaa jiraSadarkaa 1/2
  • Local Institution - 0124, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06090539

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Namoota walitti qabaa jiraSadarkaa 2
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06806033

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • University of Nebraska Medical Center (UNMC), Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Nebraska Medical Center, Omaha
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

Halt Aging in Survivors of Blood Cancers

Namoota walitti qabaa jira
  • University of Nebraska Medical Center, Omaha
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT07292272

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
  • University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT04068597

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Fred and Pamela Buffett Cancer Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 4
  • University Of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06876662

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Namoota walitti qabaa jiraSadarkaa 4
  • University Of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Bit-2026 · NCT06876649

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Omaha
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Non-Hodgkin Lymphoma magaalota biroo keessatti

Qorannoo biroo Omaha keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.